BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 37340282)

  • 21. Risk factors and a new nomogram for predicting brain metastasis from lung cancer: a retrospective study.
    Wu B; Zhou Y; Yang Y; Zhou D
    Front Oncol; 2023; 13():1092721. PubMed ID: 37404749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SMYD3 drives the proliferation in gastric cancer cells via reducing EMP1 expression in an H4K20me3-dependent manner.
    Zeng Y; Ma G; Cai F; Wang P; Liang H; Zhang R; Deng J; Liu Y
    Cell Death Dis; 2023 Jun; 14(6):386. PubMed ID: 37386026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SETDB1 tumour suppressor roles in near-haploid mesothelioma involve TP53.
    Xu M; Tu Y; Bi W; Lundberg MZ; Klooster I; Fletcher JA; Ou WB
    Br J Cancer; 2023 Aug; 129(3):531-540. PubMed ID: 37369845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SNORD6 promotes cervical cancer progression by accelerating E6-mediated p53 degradation.
    Li Q; Xie B; Chen X; Lu B; Chen S; Sheng X; Zhao Y
    Cell Death Discov; 2023 Jun; 9(1):192. PubMed ID: 37369687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic colonization potential of primary tumour cells in mice.
    Tarin D; Price JE
    Br J Cancer; 1979 Jun; 39(6):740-54. PubMed ID: 444412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA-binding proteins and exoribonucleases modulating miRNA in cancer: the enemy within.
    Seo Y; Rhim J; Kim JH
    Exp Mol Med; 2024 May; 56(5):1080-1106. PubMed ID: 38689093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DIS3L2 knockdown impairs key oncogenic properties of colorectal cancer cells via the mTOR signaling pathway.
    García-Moreno JF; Lacerda R; da Costa PJ; Pereira M; Gama-Carvalho M; Matos P; Romão L
    Cell Mol Life Sci; 2023 Jun; 80(7):185. PubMed ID: 37340282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression.
    Li Y; Zeng C; Hu J; Pan Y; Shan Y; Liu B; Jia L
    J Hematol Oncol; 2018 Jul; 11(1):89. PubMed ID: 29970122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FBXW7 circular RNA regulates proliferation, migration and invasion of colorectal carcinoma through NEK2, mTOR, and PTEN signaling pathways in vitro and in vivo.
    Lu H; Yao B; Wen X; Jia B
    BMC Cancer; 2019 Sep; 19(1):918. PubMed ID: 31519156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
    Mu Y; Zou H; Chen B; Fan Y; Luo S
    Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
    Yin F; Huang X; Xuan Y
    Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance?
    Belfiore A; Rapicavoli RV; Le Moli R; Lappano R; Morrione A; De Francesco EM; Vella V
    Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptome analysis reveals the efficacy of ginsenoside-Rg1 in the treatment of nonalcoholic fatty liver disease.
    Gu D; Yi H; Jiang K; Fakhar SH; Shi J; He Y; Liu B; Guo Y; Fan X; Li S
    Life Sci; 2021 Feb; 267():118986. PubMed ID: 33385408
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.